Search by Journal
- HOME
- > Search by Journal
- > Japanese Society of Renal Cancer meeting program
Japanese Society of Renal Cancer meeting program
Volume 24, Issue suppl / 2002
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
(1) The examination about three that showed characteristic clinical course after the IFN induction for existence metastasis renal cell carcinoma Hiroki Yamada, Masayuki Tomita, Takashi Hatano, Tetsuro Onishi, Yukihiko Oishi Japanese Society of Renal Cancer meeting program 24(suppl): 9-9, 2002. |
(2) Interferon-α, 5-FU for the progress renal carcinoma, UFT, Leucovorin, Cimetidine combination therapy 江藤正俊1), 徳田倫章2), 尾本和也1), 一倉晴彦1), 原野正彦1), 内藤誠二1) Japanese Society of Renal Cancer meeting program 24(suppl): 10-10, 2002. |
(3) A treatment outcome of IL-2 for progressive renal cell carcinoma Masashi Yamamoto, Seiichiro Osono, Uemura sky tray, Yukinari Hosokawa, Hitoshi Momose, Yuji Mochizuki, Yoshio Maruyama, Yoshinori Nakagawa, Hiroshi Yoshida Jiro, Yoshihiko Hirao Japanese Society of Renal Cancer meeting program 24(suppl): 11-11, 2002. |
(4) IL-2 for progressive renal cell carcinoma with the tumor accessory symptom, histories of treatment with the Dexamethasone combination therapy Shinojima Toshiaki, Mototsugu Oya, Takeshi Marumo, Masaru Murai Japanese Society of Renal Cancer meeting program 24(suppl): 12-12, 2002. |
(5) One cases of renal cell cancer Imunace (IL-2) monotherapy has responded to lung metastases 松岡徹1), 内田欽也1), 西村和郎2), 野々村祝夫2), 奥山明彦2) Japanese Society of Renal Cancer meeting program 24(suppl): 13-13, 2002. |
(6) Administration of IL-2 experience for progress renal cell carcinoma Osamu Saegusa still, Ryuta Tanimoto, 眞鍋大輔, Koji Ichikawa, Kenji Aramaki Japanese Society of Renal Cancer meeting program 24(suppl): 14-14, 2002. |
(7) An example of renal cell carcinoma with the distant metastasis that performance status good for a long term is obtained by an IL-2 therapy Masao Sato 1), 小石浩久 1), 四戸隆基 1), Masao Takemura 2) Japanese Society of Renal Cancer meeting program 24(suppl): 15-15, 2002. |
(8) Primary tumor non-excision renal carcinoma, one case that survives by the multiple metastases to lung, IL-2 monotherapy for anti-collateral metastases to kidney for two years Mugidani Soichi, Tetsushi Maruyama, Nagata Niburi, Shinsuke Hatano, Hiroshi Nagae Japanese Society of Renal Cancer meeting program 24(suppl): 16-16, 2002. |
(9) About antitumor immunity activity induced in patients with renal cell carcinoma during interferon alpha, an IL-2 therapy by IL-12 Norio Meguro, Toshiaki Kiuchi, Kenichi Kakimoto, Yutaka Ono, Osamu Maeda, Michiyuki Usami Japanese Society of Renal Cancer meeting program 24(suppl): 17-17, 2002. |
(10) One case of renal cell carcinoma that antiCD3 antibody coating tumor vaccine and IL-2 combination therapy were effective Tomohiko Asano, Masamichi Hayakawa Japanese Society of Renal Cancer meeting program 24(suppl): 18-18, 2002. |
(11) Interferon for the metastasis to renal carcinoma case, 5'FUDR combination therapy Matsumoto Kiyohiro, Shuichi Uejima, Chihiro Araki, Kenichi Mizoguchi, Yukio Naya, Yutaka Tobe all-out, Tatsuo Igarashi, Haruo Ito Japanese Society of Renal Cancer meeting program 24(suppl): 19-19, 2002. |
(12) The examination of the interferon alpha long-term administration example for progressive renal cell carcinoma 橋本恭伸, 中澤速和, Fumio Ito, 龍治修, Shiro Onizuka, Hisa Okuda will, Yoshiko Maeda, Hisashi Kondo virtue, Hiroshi Toma Japanese Society of Renal Cancer meeting program 24(suppl): 20-20, 2002. |
(13) Significance of the interferon alpha prophylaxis in the renal carcinoma postoperative recurrence Shuichi Osawa, Takeshi Kimura, Ryoji Kimata, Ichiro Matsuzawa, Taiji Nishimura Japanese Society of Renal Cancer meeting program 24(suppl): 21-21, 2002. |
Two cases of the V2 renal carcinoma which S-1 interferon had a complete response to Takahisa Nakamoto 1), Yoji Inoue 1), Mitsutaka Ueda 1), Sagami Koji 2), Satoshi Maruyama 3), Katsumi Inoue 4) Japanese Society of Renal Cancer meeting program 24(suppl): 22-22, 2002. |
One case of rapid growth type progress-related renal cell carcinoma where S-2 Interferon-α, cimetidine, UFT was effective 木村剛1), 三浦剛史2), 内木場拓史2), 木全亮二1), 近藤幸尋1), 堀内和孝3), 西村泰司1) Japanese Society of Renal Cancer meeting program 24(suppl): 23-23, 2002. |
Two cases of progressive renal cell carcinoma which S-3 Interleukin-2 had a complete response to Toru Yamada, 増栄成泰, Shigeaki Yokoi, Masahiro Nakano, Shinichi Ito, Yoshinori Nishino, Hidetoshi Ehara, Yoshito Takahashi, Tetsu Ishihara, Takashi Deguchi Japanese Society of Renal Cancer meeting program 24(suppl): 24-24, 2002. |
One case of the metastatic renal cell carcinoma that S-4 interferon interleukin-2 combination therapy was effective Masahiro Nakao, Yoichi Mizutani, Tsuyoshi Nomoto, Hiroyuki Nakanishi, Hiroo Nakauchi, Akihiro Kochi, Koji Miki Japanese Society of Renal Cancer meeting program 24(suppl): 25-25, 2002. |
Clinical discussion of the S-5 renal carcinoma immunotherapy (including the chemotherapy) effective case 福田百邦 1), Oofuru Yoshiji 2), Sumio Noguchi 2) Japanese Society of Renal Cancer meeting program 24(suppl): 26-26, 2002. |